Axis Focused Fund
Direct · GrowthAI Summary
Axis Focused Fund has delivered SIP XIRR of 12.19% over 3Y and 12.51% over 5Y, but this trails the category average SIP XIRR of 15.84% (3Y) and 15.54% (5Y) by a meaningful margin. Against the NIFTY 50, the fund shows positive alpha of 4.96% over 1Y and 3.68% over 3Y, though 5Y alpha is negative at -2.47%. Long-term lump-sum performance remains solid, with 12Y Fund CAGR of 12.23% versus the benchmark's 9.2%.
The fund exhibits defensive characteristics with a beta of 0.90-0.96 across periods and consistently lower downside capture (88-94%) than upside capture (91-98%), cushioning losses in weak markets. Calmar ratios are stable around 0.41-0.45 across horizons, indicating consistent risk-adjusted returns. However, the fund has experienced 8 drawdown events exceeding 10%, and the recent 1Y XIRR of 8.27% reflects a soft patch.
The 28-stock focused portfolio is led by ICICI Bank (7.59%), Eternal (6.09%), and Divi's Laboratories (5.27%), with financials dominating — Banks at 18.4% plus Finance at 8.9% totals roughly 27% of the portfolio. Healthcare exposure via Divi's Labs and Apollo Hospitals (combined ~10.4%) adds a defensive tilt. The concentrated 28-holding structure means single-stock and sector moves will have outsized impact relative to diversified funds.
The fund has underperformed the category average SIP XIRR across every measured horizon, lagging by roughly 3 percentage points at 3Y (12.19% vs 15.84%) and 10Y (12.56% vs 15.71%). Its benchmark record is more encouraging, with positive alpha over 1Y, 3Y, 10Y, 12Y, and 15Y periods. This suggests the fund competes better against the index than against focused-fund peers, where it sits in the lower half.
This fund suits investors seeking a concentrated, benchmark-beating core holding with moderate downside protection, and who can tolerate periods of peer underperformance. A horizon of 7 years or more is appropriate, given the fund's strongest long-term lump-sum rolling returns (14%+ over 7Y-12Y windows). Investors prioritizing top-quartile category performance may want to compare alternatives before committing.
- Consistently lower downside capture (88-91% over 7Y-15Y) than upside capture, providing cushioning in falling markets
- Positive alpha versus NIFTY 50 over 1Y (4.96%), 3Y (3.68%), 10Y (1.52%), and 12Y (3.27%) periods
- Reasonable expense ratio of 0.87% for a Direct plan with a concentrated, high-conviction 28-stock portfolio
- SIP XIRR trails the category average across all horizons, including 12.19% vs 15.84% over 3Y and 12.56% vs 15.71% over 10Y
- Negative 5Y alpha of -2.47% versus NIFTY 50 and weak recent calendar-year returns (3.24% in 2025, -2.53% in 2026 YTD)
Generated on 17-10-2026, 5:01 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.77 L | 16.2% | -45.2% | 89.1% |
| 3 Years | ₹36.00 L | ₹43.62 L | 13.8% | -11.7% | 38.1% |
| 5 Years | ₹60.00 L | ₹82.08 L | 13.6% | 0.4% | 26.5% |
| 7 Years | ₹84.00 L | ₹1.31 Cr | 13.3% | 5.7% | 22.9% |
| 10 Years | ₹1.20 Cr | ₹2.32 Cr | 12.6% | 8.5% | 16.0% |
| 12 Years | ₹1.44 Cr | ₹3.22 Cr | 12.5% | 9.7% | 15.1% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 16.2% | 14.3% | 11.2% | +1.9% |
| 3 Years | 13.8% | 11.0% | 15.8% | +2.8% |
| 5 Years | 13.6% | 10.4% | 15.5% | +3.2% |
| 7 Years | 13.3% | 10.6% | 15.1% | +2.7% |
| 10 Years | 12.6% | 11.4% | 15.7% | +1.2% |
| 12 Years | 12.5% | 11.3% | 15.1% | +1.2% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 15.3% | 12.1% | -19.4% | 77.6% | 0.48 | 1.33 | 80% | — | — |
| 3 Years | 14.1% | 14.3% | 2.4% | 27.1% | 1.55 | 17.65 | 100% | — | — |
| 5 Years | 14.2% | 14.1% | 1.9% | 25.2% | 1.69 | 20.54 | 100% | — | — |
| 10 Years | 13.9% | 13.8% | 11.1% | 16.4% | 5.88 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +3.54 | 0.95 | 95.2% | 90.5% | -5.2% | -9.5% |
| 3 Years | +3.27 | 0.92 | 94.9% | 90.0% | 8.8% | 5.5% |
| 5 Years | -2.51 | 0.94 | 91.4% | 93.9% | 2.2% | 4.6% |
| 7 Years | -0.18 | 0.89 | 91.2% | 90.7% | 9.9% | 10.6% |
| 10 Years | +1.45 | 0.90 | 91.7% | 89.3% | 11.6% | 10.5% |
| 12 Years | +3.21 | 0.91 | 93.2% | 89.0% | 12.5% | 9.6% |
| 15 Years | +2.63 | 0.90 | 92.2% | 88.3% | 11.8% | 9.4% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | ICICI Bank Limited | 7.59% |
| 2 | Eternal Limited | 6.09% |
| 3 | Divi's Laboratories Limited | 5.27% |
| 4 | Apollo Hospitals Enterprise Limited | 5.12% |
| 5 | Cholamandalam Investment and Finance Company Ltd | 4.61% |
| 6 | Bajaj Finance Limited | 4.28% |
| 7 | State Bank of India | 4.16% |
| 8 | PB Fintech Limited | 3.96% |
| 9 | Apar Industries Limited | 3.51% |
| 10 | Axis Bank Limited | 3.34% |